Dr. Reddy’s Laboratories announces acquisition of ANDA portfolio

This article was originally published here

The portfolio includes more than 30 generic injectable products. These products will require to be technology transferred and could be launched within the next one to two years.

The post Dr. Reddy’s Laboratories announces acquisition of ANDA portfolio appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply